Geneyx Genomex vs FORE Biotherapeutics
Geneyx Genomex vs FORE Biotherapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Geneyx Genomex is on 55/100 and FORE Biotherapeutics on 56/100.
Where each one leads
Geneyx Genomex
- agent readiness: 50/100 against 37/100
- domain rating: 44/100 against 33/100
- headcount growth: +12.1% against +8.2%
- LinkedIn following: 6,977 against 4,584
FORE Biotherapeutics
- headcount: 56 against 31
- funding raised: $232M against $10.0M
At a glance
| Measure | Geneyx Genomex | FORE Biotherapeutics |
|---|---|---|
| What it is | Harnessing genetic data for digital insights in rare and germline disorders. | Precision oncology company developing cancer therapies guided by proprietary functional genomics. |
| Category | Healthcare, Genomics, Diagnostics, Clinical | Healthcare, Drug Development, Genomics, Next Generation Sequencing |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2018 | 2011 |
| Headquarters | Tel Aviv, Israel | Philadelphia, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Geneyx Genomex | FORE Biotherapeutics |
|---|---|---|
| Employees | 31 | 56 |
| Headcount growthLast 12 months | +12.1% | +8.2% |
| Total funding | $10.0M | $232M |
| Latest round | Seed | Series D-2 Extension |
| Valuation | Not published | $75.0M |
| LinkedIn followers | 6,977 | 4,584 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Geneyx Genomex | FORE Biotherapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 56/100 |
| Traction | 50/100 | 58/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 25/100 | 38/100 |
| Quality | 58/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | 44/100 | 33/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Geneyx Genomex | FORE Biotherapeutics |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
Geneyx Genomex vs FORE Biotherapeutics: common questions
Which is better, Geneyx Genomex or FORE Biotherapeutics?
On our 0-100 score FORE Biotherapeutics rates higher (56/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Geneyx Genomex and FORE Biotherapeutics compare on the numbers?
Geneyx Genomex leads on agent readiness (50/100 against 37/100), domain rating (44/100 against 33/100), headcount growth (+12.1% against +8.2%), LinkedIn following (6,977 against 4,584). FORE Biotherapeutics leads on headcount (56 against 31), funding raised ($232M against $10.0M).
Read the full Geneyx Genomex review and pricing or the FORE Biotherapeutics review and pricing. You can also browse other Geneyx Genomex alternatives we track.